Kallieri M, Zervas E, Fouka E, Porpodis K, et al. RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: evaluating the multiple components of response. Allergy 2022 May 20. doi: 10.1111/all.15382.
PMID: 35595723